SEC 13F Intelligence

Dekabank Deutsche Girozentrale / ELV

Dekabank Deutsche Girozentrale’s Elevance Health Inc Formerly Position

Does Dekabank Deutsche Girozentrale own Elevance Health Inc Formerly (ELV)? Yes343.3K shares worth $101M (+0.17% of its 13F portfolio) as of Q1 2026.

Position Value
$101M
Q1 2026
Shares
343.3K
% of Portfolio
+0.17%
Quarters Held
29
currently held

Position History ELV

Reported value by quarter
Q4 ’18: $32MQ4 ’18Q1 ’19: $30MQ2 ’19: $47MQ3 ’19: $28MQ4 ’19: $11MQ4 ’19Q1 ’20: $8MQ2 ’20: $9MQ3 ’20: $24MQ1 ’21: $32MQ1 ’21Q2 ’21: $36MQ3 ’21: $46MQ4 ’21: $61MQ1 ’22: $112MQ1 ’22Q2 ’22: $129MQ3 ’22: $129MQ4 ’22: $160MQ1 ’23: $146MQ1 ’23Q2 ’23: $147MQ3 ’23: $152MQ4 ’23: $159MQ1 ’24: $184MQ1 ’24Q2 ’24: $185MQ3 ’24: $179MQ4 ’24: $126MQ1 ’25: $152MQ1 ’25Q2 ’25: $131MQ3 ’25: $110MQ4 ’25: $201MQ1 ’26: $101MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026343.3K$101M+0.17%
Q4 2025343.3K$201M+0.35%
Q3 2025343.3K$110M+0.18%
Q2 2025343.3K$131M+0.23%
Q1 2025356.0K$152M+0.30%
Q4 2024343.3K$126M+0.23%
Q3 2024343.3K$179M+0.33%
Q2 2024344.2K$185M+0.33%
Q1 2024356.0K$184M+0.34%
Q4 2023340.4K$159M+0.33%
Q3 2023340.1K$152M+0.35%
Q2 2023333.1K$147M+0.33%
Q1 2023319.3K$146M+0.37%
Q4 2022316.0K$160M+0.42%
Q3 2022284.4K$129M+0.38%
Q2 2022266.5K$129M+0.37%
Q1 2022223.2K$112M+0.27%
Q4 2021130.6K$61M+0.15%
Q3 2021118.5K$46M+0.13%
Q2 202196.2K$36M+0.11%
Q1 202187.3K$32M+0.10%
Q3 202091.9K$24M+0.10%
Q2 202037.0K$9M+0.06%
Q1 202036.9K$8M+0.06%
Q4 201936.0K$11M+0.07%
Q3 2019114.9K$28M+0.17%
Q2 2019166.3K$47M+0.24%
Q1 2019113.6K$30M+0.18%
Q4 2018121.9K$32M+0.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of ELV.